Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
RUA Life SciencesLSE:RUA +4.35%47 Days Inventory is 227.00 as of Mar. 2026, which is 117% above its 10-year median of 104.42. GuruFocus rates LSE:RUA with a GF Score™ of 47/100 and a GF Value™ of £0.17 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 787 Medical Devices & Instruments companies, RUA Life Sciences ranks worse than 89.2% on this metric.
The historical rank and industry rank for RUA Life Sciences's Days Inventory or its related term are showing as below:
LSE:RUA'
s Days Inventory Range Over the Past 10 Years
Min: 84.87 Med: 104.42 Max: 454
Current: 454
During the past 13 years, RUA Life Sciences's highest Days Inventory was 454.00. The lowest was 84.87. And the median was 104.42.
LSE:RUA's Days Inventory is ranked worse than 89.2% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 179.73
vs LSE:RUA: 454.00
RUA Life Sciences's Days Inventory
declined
from Sep. 2024 (438.00) to Mar. 2026 (227.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
RUA Life Sciences's Inventory Turnover for the
six
months ended in Mar. 2026 was 0.80.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
RUA Life Sciences's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.31.
RUA Life Sciences (LSE:RUA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
RUA Life Sciences's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
RUA Life Sciences's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
RUA Life Sciences Days Inventory Related Terms
RUA Life Sciences Days Inventory Historical Data
* Premium members only.
The historical data trend for RUA Life Sciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:RUA vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, RUA Life Sciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RUA Life Sciences Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, RUA Life Sciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where RUA Life Sciences's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RUA Life Sciences (LSE:RUA) has a Days Inventory of 227.00 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on RUA Life Sciences and its competitors. This is 117% above median its historical median of 104.42. Over the past decade, RUA Life Sciences' Days Inventory has ranged from 84.87 to 454.00. According to the industry distribution chart, RUA Life Sciences ranks #702 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 89.2%.
Is RUA Life Sciences' Days Inventory too high?
RUA Life Sciences' current Days Inventory of 227.00 is 117% above median its 10-year median of 104.42. Over the past 10 years, this metric has ranged from a low of 84.87 to a high of 454.00. The Medical Devices & Instruments industry median Days Inventory is 179.73. RUA Life Sciences' value of 227.00 is 26.3% above this industry median. Based on the distribution chart, RUA Life Sciences ranks #702 out of 787 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, RUA Life Sciences has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does RUA Life Sciences' Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, RUA Life Sciences ranks #702 out of 787 companies for Days Inventory. This places RUA Life Sciences in the lower half of its industry. The industry median Days Inventory is 179.73. RUA Life Sciences' value of 227.00 is 26.3% above this benchmark. Historically, RUA Life Sciences' own Days Inventory has ranged from 84.87 to 454.00 over the past decade. While the company's 10-year median is 104.42 vs. the industry median of 179.73, RUA Life Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.73, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RUA Life Sciences's current Days Inventory of 227.00 is 26.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on RUA Life Sciences and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RUA Life Sciences's current Days Inventory is 227.00, which is 117% above median its own 10-year median of 104.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RUA Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, RUA Life Sciences (LSE:RUA) is currently considered Significantly Overvalued. The stock's GF Value™ is £0.17, compared to a current price of £0.24 — trading 41.2% above its estimated fair value. The current Days Inventory is 227.00, which is 117% above median its 10-year median of 104.42 and 26.3% above the Medical Devices & Instruments industry median of 179.73. RUA Life Sciences' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For RUA Life Sciences (LSE:RUA), the current Days Inventory is 227.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RUA Life Sciences (LSE:RUA) Overvalued in 2026?
Based on GuruFocus' analysis, RUA Life Sciences stock appears to be overvalued.
The current stock price of £0.24 is trading 41.2% above its estimated GF Value™ of £0.17.
GuruFocus considers RUA Life Sciences to be Significantly Overvalued.
Key valuation signals for LSE:RUA:
Days Inventory: 227.00 (117% above median its 10-year median of 104.42)
GF Value™: £0.17 vs. price of £0.24 (41.2% above fair value)
Industry Position: 26.3% above the Medical Devices & Instruments median (#702 of 787)
No single metric tells the full story. See the LSE:RUA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RUA Life Sciences PLC is engaged in the contract design and manufacture of medical devices, exploiting the value of its IP and know-how, and developing cardiovascular devices. The Biomaterials segment is a licensor of Elast-Eon polymers to the medical device industry. The Medical Devices & Components segment is an end-to-end contract developer and manufacturer of medical devices and an implantable fabric specialist, which generates maximum revenue. The Vascular segment focuses on the development and commercialisation of the Group's Elast-Eon sealed Vascular Graft products. The Structural Heart segment focuses on the development of the Group's tri-leaflet polymeric heart valves. Geographically, it operates in Europe, North America, Middle East, Asia Pacific, and Africa.
47GF Score
Get the complete analysis for LSE:RUA
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:RUA has been successfully added to your 
